Literature DB >> 9746036

Children are not small adults.

P Moore.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9746036     DOI： 10.1016/S0140-6736(05)79591-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

2.  Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.

Authors:  Michael L Rinke; David G Bundy; Aaron M Milstone; Kristin Deuber; Allen R Chen; Elizabeth Colantuoni; Marlene R Miller
Journal:  Jt Comm J Qual Patient Saf       Date:  2013-08

Review 3.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Mindfulness-Based Intervention Development for Children and Adolescents.

Authors:  David Saunders; Hedy Kober
Journal:  Mindfulness (N Y)       Date:  2020-05-19

5.  Trends in accessibility to medicines for children in New Zealand: 1998-2002.

Authors:  Jocelyn Chui; June Tordoff; Julia Kennedy; David Reith
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

Review 6.  Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Authors:  Venkata K Yellepeddi; Andrea Joseph; Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-09-05       Impact factor: 15.470

Review 7.  The Need for Pediatric Formulations to Treat Children with HIV.

Authors:  Adrienne F Schlatter; Andrew R Deathe; Rachel C Vreeman
Journal:  AIDS Res Treat       Date:  2016-06-16

Review 8.  Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.

Authors:  Tatjana Welzel; Carolyn Winskill; Nancy Zhang; Andreas Woerner; Marc Pfister
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-25       Impact factor: 3.054

9.  Development of an observational exposure human biomonitoring study to assess Canadian children's DEET exposure during protective use.

Authors:  Jennifer C Gibson; Leonora Marro; Michael M Borghese; Danielle Brandow; Lauren Remedios; Mandy Fisher; Morie Malowany; Katarzyna Kieliszkiewicz; Anna O Lukina; Kim Irwin
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

10.  Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.

Authors:  María Del Mar Castro; Maria Adelaida Gomez; Anke E Kip; Alexandra Cossio; Eduardo Ortiz; Adriana Navas; Thomas P C Dorlo; Nancy Gore Saravia
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.